This exempt, minimal risk, prospective, post-market, registry, multi-center, Institution Review Board (IRB) approved observational clinical evaluation was conducted at 10 centers. A total of 197 patients were enrolled. The evaluation collected data in a real-world patient population and was a data collection initiative only. No patient treatments or care were performed as a component of the protocol. All patient care received was on-label and standard of care for lateral lumbar interbody fusions. The data collected in this evaluation is intended to contribute to the body of literature for lateral lumbar interbody fusions.
The purpose of this study was to collect data that reports on the clinical outcomes of patients that were treated with the Spineology Rampart DUO device in a standard of care instrumented lateral lumbar interbody fusion procedure at one or two contiguous levels from L2-L5. Data was collected prospectively at specified time points per protocol and included both objective and subjective measures. The study concluded when the final patient achieved their 12-month evaluation.
Study Type
OBSERVATIONAL
Enrollment
197
There is no intervention performed in this evaluation. Data is being collected in an on-label standard of care lateral lumbar interbody fusion procedure.
Bell Neuroscience Institute/Washington Township Medical Foundation
Fremont, California, United States
Loma Linda University
Loma Linda, California, United States
Napa Valley Orthopaedic Medical Group
Napa, California, United States
Short-term objective 1: New onset of thigh symptoms -- Anterior Thigh Pain Change from Baseline
Change from Baseline anterior thigh pain score through 3-months. Pain assessment captured on 100 mm VAS. A higher VAS score represents a worsening of pain.
Time frame: 3 months
Short-term objective 1: New onset of thigh symptoms -- Thigh Neurological Change from Baseline
Change from baseline in anterior thigh neurological assessment through 3 months. Anterior Thigh Neurological deficit defined as a negative change in strength (hip/flexor weakness) or sensation (anterior thigh).
Time frame: 3 months
Short-term objective 2: Hospital economics -- Blood Loss
Estimated blood loss (EBL) shall be compared to published literature.
Time frame: EBL collected at time of surgery.
Short-term objective 2: Hospital economics -- Duration of Surgery
Duration of surgery (DoS) defined as time from incision to closure shall be compared to published literature.
Time frame: DoS collected at time of surgery.
Short-term objective 2: Hospital economics -- Time-to-Discharge
Time-to-discharge (TTD) defined as time from hospital admission to the time the subject is discharged from the hospital and it shall be compared to published literature.
Time frame: Perioperative.
Long-term objective 1: Patient Low back pain change over time
Pain measured on 100 mm VAS and compared to baseline.
Time frame: Through 12 months postoperative.
Long-term objective 1: Patient Low back function change over time
Low back function determined on Oswestry Disability Index (ODI) and compared to baseline.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Georgetown University Hospital
Washington D.C., District of Columbia, United States
South Florida Spine & Orthopedics
Coconut Creek, Florida, United States
Orthopaedic Institute of Western Kentucky
Paducah, Kentucky, United States
Spine Institute of Louisiana
Shreveport, Louisiana, United States
Orthopedic Institute of Pennsylvania
Camp Hill, Pennsylvania, United States
Austin Spine Specialists
Austin, Texas, United States
Spine Works Institute
North Richland Hills, Texas, United States
Time frame: Through 12 months postoperative.
Additional Outcomes 1 - Radiographic Assessments
Assess for fusion status
Time frame: Assessed at 12 months postoperative.